Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis

Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease

(2014) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

Systematic Reviews of Diagnostic Test Accuracy

(2013) Mariska M.G. Leeflang   ANNALS OF INTERNAL MEDICINE

Lactoferrin – 50 years on

(2012) Jeremy H. Brock   Biochemistry and Cell Biology

Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort

(2012) Emanuel Burri et al.   CLINICA CHIMICA ACTA

A Global Perspective on Irritable Bowel Syndrome

(2012) Eamonn M. M. Quigley et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Faecal lactoferrin - a novel test to differentiate between the irritable and inflamed bowel?

(2010) R. SIDHU et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010

(2009) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease

(2009) Manohara Joishy et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers

(2009) S. Joshi et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

(2008) Charlotte M.T. Otten et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

(2008) Jennifer Jones et al.   Clinical Gastroenterology and Hepatology

Review of Fecal Biomarkers in Inflammatory Bowel Disease

(2008) Andrew D. Sutherland et al.   DISEASES OF THE COLON & RECTUM

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

(2007) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES